markers specific for T and/or B cells. The established cell line produces both basic fibroblast growth factor and transforming growth factor-@, properties demonstrated previously for the solid tumor. The clonal cell population exhibited a unique, singular karyotype, indicating cellular homogeneity. The cells display a doubling time of approximately 33 hours in either 25% horse or calf serum.
Treatment of the cells with 1 x IO-* mol/L phorbol 12-myristate 13-acetate (PMA) leads to the induction of multi-nucleation and hyperploidy in the cells, with approximately 35% of the cells exhibiting two or more nuclei per cell, and greater than 80% of the cells enlarging in size. The establishment of this unique cell line under defined culture conditions will be beneficial for the future study of megakaryocytic properties expressed by this cell line. 0 1990 by The American Society of Hematology.
have been shown to apparently undergo some differentiation along the megakaryocytic lineage by the addition of phorbol esters. It is thus apparent that useful information concerning megakaryopoiesis, and megakaryocytes in general, can be obtained through the study of such cell lines.
We have recently described a megakaryoblastic cell line that has been successfully passaged in nude mice for over 3 years.I4 This line, designated CHRF-288, was originally established from a biopsy of a metastatic tumor in a 17-month-old infant with acute megakaryoblastic leukemia. We have been able to demonstrate that this line synthesizes a unique subset of growth factor^,'^ some of which are normally associated with platelets. In order to facilitate the study of platelet-specific proteins in this cell line, it would be advantageous to establish the CHRF-288 cell line in culture. We now report that this effort has been successful through the use of a feeder layer consisting of adherent stromal cells in long-term human marrow cultures. In normal marrow these are the cells that support hematopoiesis,I6 and the conditions for establishing such cultures have been available for a number of year^.'^.'^ The tumor cells were weaned from the stromal layer, cloned, and were shown to express characteristics of the cells grown in athymic nude mice (as determined morphologically, biochemically, immunologically, and karyotypically). Exposure of these cells to phorbol 12-myristate 13-acetate (PMA) leads to multinucleation in the absence of cytokinesis, indicating that the cells may be induced to differentiate along the megakaryocytic lineage. This cell line could, therefore, prove to be a useful system in which to study aspects of megakaryocytic differentiation and the regulation of various platelet-specific functions. In addition, this in vitro system may also provide for a unique approach to study important interactions between the supportive elements of the bone marrow and megakaryoblasts.
MATERIALS AND METHODS
The CHRF-288 tumor line was propagated in nude mice as previously des~ribed.'~.'' Propagation of the solid tumor line, CHRF-288. BMMC were also reclaimed from the soy bean lectin agglutinate fraction of the T-cell depletion p d u r e by disaggregating the cells with 0.2 mol/L galactose in PBS. washing the separated cells two times with Media 199. I % penicillin/streptomycin, and resuspending them to a final cell concentration of 5 x 10' cells/mL. The cultures of stromal layers derived from the lectin agglutinate fraction would not give rise to hematopoietic cells as the stem cell population had been removed; however. the stromal cell layer obtained from this population of cells was equally effective a s a feeder layer as were the cells salvaged from the red cell sediment. Both types of stromal cell populations were used in our experiments.
although they were never mixed together before initiating the stromal cultures. Long-term bone marrow (LTBM) cultures were established by plating 3 to 5 x IO' BMMCs in 25 cm'tissueculture consisting of Fischer's complete media for leukemic cells. 25% horse serum. and I% penicillin/streptomycin. Initially. I rmol/L hydrocortisone was added to the media and cells were incubated in a 37O. 100% humidified incubator with 5% CO, in air. After 5 or 6 days, all nonadherent cells (which would contain hematopoietic stem cells) were removed: the adherent cells were washed with media, and fresh LTBM media was added. Cultures were then fed weekly by removal of all media and replacement with fresh LTBM media. Hydrocortisone was removed from the culture media after 4 weeks of culture, and always before a culture's use a s a feeder laycr. From these cultures. stromal layers developed that consisted of fibroblasts, adipocytes. and macrophages. as is evident in Fig I A. The removal of nonadherent cells from the cultures was important to select against long-term development of hematopoietic cells.
I n vitro establishment of the megakaryocytic leukemic cell line CHRF-288-1I. While CHRF-288 cells grow well within the nude mouse a s solid tumors, such growth precludes the use of the cell line for many valuable experiments. In order to adapt these cells to in vitrogrowth. the marrow microenvironment was mimicked as closely as possible by using an in vitro system of stromal cells obtained from long-term human bone marrow cultures for use a s a f d e r layer. All other attempted procedures that did not use LTBM feeder layers were unsuccessful. Two such LTBM cultures were inoculated with a CHRF-288 cells were weaned from the stromal layer over a period of 4 months. Cells that were spontaneously released from the stromal layer were collected and plated into a new dish in the absence of stromal cells. Some stromal cells were carried over by this procedure, however, and attached to the flask and proliferated. However, many of the CHRF-288 cells remained unattached to the stromal cells, and the process of replating was repeated. This continued until no further stromal cells were being carried over, and the CHRF-288 cells had obtained the capacity to grow in the absence of such cells, providing that the initial seeding density was high (lo' cells per flask). At low densities, cell proliferation did not occur. Thus, in order to clone the cells, it was necessary to perform the procedure (limiting dilution) on LTBM cultures. Fourteen independent clones were isolated, removed from the stromal layer, and grown in culture. One clone, clone 11 (designated CHRF-288-1 l), was chosen for the experiments described below. The CHRF-288-11 cells are passaged in the absence of feeder layers by biweekly feeding in Fishers medium supplemented with either horse or bovine calf serum.
In situ photomicrographs of unstained viable cultures were taken on a Zeiss inverted stage microscope using Hoffman modulation optics. Cytocentrifuge preparations of the cultured tumor cells were stained with Wright's stain on an Ames Hema-Tek slide stainer (Miles) followed by a manual 5 minute Giemsa stain for routine light microscopic analysis. Cells for routine electron microscopy were fixed in 3% glutaraldehyde in 0.175 mol/L cacodylate buffer and post-fixed in 1% osmic acid before embedding in LX112. Uranyl acetate stained sections were examined with a Phillips 400 transmission electron microscope. Tumor cells were processed for the platelet peroxidase reaction as previously described.2' Negative controls for the platelet peroxidase reaction were processed in an identical manner, except that hydrogen peroxide was omitted from the reaction mixture.
Flow cytometry. Monoclonal antibodies were obtained from Ortho Diagnostics (Raritan, NJ; OKT series), Becton/Dickinson (Mountain View, CA; Leu series, recombinant interleukin-2 [IL2-R], and common acute lymphoblastic leukemia antigen [CALLA]) and from Coulter Immunology (MY7, MY9; Hialeah, FL). CHRF-288-11 cells used for flow cytometry were grown in Fischers medium containing 25% horse serum, washed twice with PBS, 2% horse serum, pH 7.4, incubated with fluorescein-labeled mouse monoclonal antibodies at 5 x lo6 cells/mL for 30 minutes at 4°C with occasional shaking, and washed twice in PBS before analysis. Cells labeled by indirect methods were processed as described above, washed twice in PBS, 2% horse serum, incubated 30 minutes on ice with fluorescein-labeled goat anti-mouse IgG with occasional shaking, and washed twice with PBS before analysis. The antibody incubations were all performed between concentrations of 0.5 to 25 pg/mL. Ten thousand cells were counted per determination. The DNA content of the cells was measured using an EPICS flow cytometer equipped with digitalizing equipment. Cells for DNA analysis were prepared as described,22 except that before analysis the labeled cell suspension was filtered through an 88 pm nylon mesh filter to remove any agglutinated cells.
CHRF-288-11 cells were incubated in serum-free media for 24 hours to allow serum factors to dissociate
Microscopy.
Immunocytochemistry. from the cells, and then cytocentrifuged on poly-L-lysine coated glass slides for immunohistochemistry. The slides were air dried and rinsed in three changes of PBS buffer containing 1% bovine serum albumin (BSA). The antibodies were obtained from Accurate Chemical and Scientific Co (Westbury, NY; anti-factor VI11 antigen), Dr Shirley Levine (San Antonio, TX; anti-platelet factor 4 [PF4]), Dr William Dean (Louisville, KY; anti-human platelet Ca+ +-adenosine triphosphatase [ATPase]), Dr Ronald Jensen (Lawrence Livermore Laboratories, Livermore, CA, anti-glycophorin A), Dr Rodger McEver (Oklahoma Medical Research Foundation, Oklahoma City, OK; anti-platelet glycoprotein IIb-IIIa), and the DAKO Corporation (Santa Barbara, CA) for antibodies against myeloperoxidase. Nonimmune rabbit and mouse sera were used as negative controls. Immunofluorescence-stained slides were analyzed with a Zeiss epifluorescence microscope. Results obtained using cells pre-incubated in serum-free media for 24 hours were the same as those obtained using cells without serum-free pre-incubation, and the results were similar if the cells were grown in either horse or calf serum.
Karyotype analysis of the growing cells was performed using standard procedures, which have been described previo~sly.~'
Western analysis for the presence of glycophorin A was carried out as describedz4 using monoclonal antibody 10F7 at a dilution of 1:200.
Growth factor analysis. For the determination of growth factor activity in CHRF-288-11 cell extracts, the cells were extracted in either a neutral buffer (1 x lo6 cells in 1 .O mL of 20 mmol/L Tris, 0.25 mol Sucrose, 1 mmol/L EDTA, 0.1 mmol/L phenylmethylsulfonyl fluoride [PMSF], pH 7.0) or in an acidic buffer (4.8 x lo6 cells in acidic ethan~l).~' Neutral homogenates were clarified by centrifugation, and aliquots were added directly to serum-depleted 3T3-NR6 cells as previously described." Measurement of analysis of the ['HI-thymidine incorporation into DNA was performed as described." Acidic ethanol extracts were concentrated by ether precipitation" and dissolution of the pellet in 200 pL 4 mmol/L HCI. Aliquots of this extract were added to high density, exponentially growing A549 cells as described," and the extent of inhibition of DNA synthesis was determined.
The methods for all procedures are described below. Total RNA was isolated from 1 x 10' cells (or 1 g of CHRF-288 solid tumor tissue)" as described previously.26 For Northern analysis, the total RNA was passed through an oligo-dT column to purify polyA+-RNA. Northern analysis of transforming growth factor-81 (TGF-81) mRNA was performed according to a modification of the previously described proced~re.~' After electrophoresis, RNA was transferred to nitrocellulose and prehybridized for 4 hours at 42" in 20 x SSC (1 x SSC contains 0.1 5 mol/L NaC1, 0.015 mol/L sodium citrate), 50 mmol/L sodium phosphate, 2 x Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), and 50% formamide. The TGF-81 probe (pBas; Genentech, San Francisco, CA2*) was labeled using the random primer technique.29 Hybridization with ['2P]-labeled cDNA probe, at 1 x lo6 cpm/mL, was carried out for 16 hours at 42" in 4 x SSC, 40 mmol/L sodium phosphate, 2x Denhardt's solution, 0.1% SDS, and 40% formamide. After hybridization, filters were washed four times at room temperature in 2 x SSC containing 0.2% SDS for 5 minutes and again for 20 minutes. Subsequent washes were two times in 0.2 x SSC containing 0.2% SDS at 50" and once in 0.1 x SSC containing 0.1% SDS at 55". The filter was then exposed to Kodak XAR film at -70" with an intensifying screen for 15 hours before development.
Quantitation of basic fibroblast growth factors (bFGF) mRNA was done by solution hybridization. A vector was constructed that contained the 474 bp human bFGF insert from the plasmid mp18 + bFGF, which was generously provided by Synergen, BoulKaryotype analysis.
Western analysis.
RNA analysis.
For personal use only. It was then determined. both microscopically and immunologically, that the megakaryocyte-specific genes that were expressed in the solid tumor were still expressed in the cultured cells; ie, the cells were phenotypically unchanged. Light microscopic analysis of Wright-Giemsa stained cells (Fig 2) demonstrated that the cells ranged in size from 15 to 20 pm in diameter, contained a highly basophilic, slightly granular cytoplasm with a prominent eosinophilic perinuclear Golgi zone. Most of the cells had a single oval or rounded nucleus with one to three prominent nucleoli. Cells with bilobed nuclei were occasionally present (2% to 3% of the total), and a few cells had complex multilobed nuclei (less than 0.5% of the population). Several cells with cytoplasmic protrusions were also observed, although the majority of cells were rounded. Immunohistochemistry demonstrated the presence of platelet glycoprotein Ilb-llla and factor Vlll antigen. characteristics of both platelets and megakaryocytes (Fig 3A and B) . Greater GPllb-llla, while 30% to 40% of the population expressed factor V l l l antigen. The factor Vlll positive cells were generally the larger, more mature cells but also included many immature cells that showed little cytologic evidence of maturation. Immunohistochemistry on acetone permeabilized cells identified a diffuse staining for PF4 antigen in the cytoplasm (Fig 3C) . as well as platelet Ca' '-ATPase immunoreactivity (Fig 3D) . In contrast to the factor Vlll stain, PF4 was generally expressed in most cells, although there was more cell to cell variability in intensity, and the PF4 signal was focally concentrated in many of the cells. Myeloperoxidase immunoreactivity was not detected (not shown).
RESULTS

Characteristics
Electron microscopy ( Figs 4A. B. C, and D) showed most of the cells had a single nucleus with a single prominent nucleolus, and the chromatin was moderately condensed. Most of the cells contained few cytoplasmic organelles other than large numbers of polyribosomes. The more mature cells (Fig 4A) generally had extensive rough endoplasmic reticulum. frequent mitochondria, and a well-developed Golgi complex associated with numerous small vesicles. some of which were coated. There were also numerous granules that varied in size and electron density. Small round granules (100 to 300 nm) were evident, and contained an electron dense matrix that either completely filled the granule or was surrounded by a clear halo in the more differentiated cells. These granules could generally be seen budding near the Golgi complex but occasionally could be seen to arise from areas of the endoplasmic reticulum in the periphery of the cells (Fig 4C) . Ultrastructural features of the smaller dense For personal use only. on September 14, 2017. by guest www.bloodjournal.org From granules resemble the various stages of platelet dense granule formation as described by White." Larger granules (300 to 600 nm). resembling a-granules, had a diffuse, finely granular matrix and, occasionally, a moderately dense nucleoid (Fig 4B) . The platelet peroxidase reaction (Fig 4D) as analyzed by electron microscopy was positive in greater than 80% of the cells. The reaction product was localized to the perinuclear zone and in the endoplasmic reticulum.
Cloned CHRF-288-1 I cells were also examined by flow cytometric analysis for the expression of cell surface markers characteristic of T cells, B cells, natural killer cells, lymphoblastic leukemia, monocytes. and megakaryocytes. As can be seen in Table I . the CHRF-288-11 cells expressed the HLA-DR backbone antigen, GPIlb-llla, and epitopes recognized by MY7 (CD13) and MY9 (CD33) monoclonal antibodies. No T and B cell markers were evident on the cell, nor was there evidence for the expression of glycophorin A by Western blot analysis (Fig 5) . immunocytochemistry (data not shown), or hemoglobin as determined by immunocytochemistry (not shown). Benzidine staining also failed to reveal the presence of heme (data not shown). These data would indicate that the line is expressing megakaryocytic markers, and that it is not biphenotypic for the erythroid lineage.
Clone I 1 was also examined for the production of bFGF and TFG-& two factors shown to be synthesized in large quantity by the solid tumor from which these cells were d e r i~e d . '~ Northern blot analysis of the RNA from the (Fig 6) using a probe specific for TGF-BI showed a strong hybridization signal at 2.2 kb. identical to the signal in the megakaryocyte solid tumor RNA. This indicates that CHRF-288-11 cells produce TFG-BI message, and the data in Table 2 indicate that a TGF-191 activity is also present in cell extracts. Solution hybridization analysis of total RNA prepared from the cultured cells for bFGF transcripts indicates the presence of such transcripts (Fig 6) . Full length bFGF mRNA protected a fragment 474 bases long. as well as a fragment 446 bases long in equal abundance. The 474 base band corresponds to the size of the control sense strand signal, which did not show any other bands (data not shown). This indicates that the 446 base band resulted from cellular processing of the mRNA. The quantities of each species were determined based upon densitometric comparison with the results of hybridization to synthesized sense strand RNA from the same riboprobe vector." The cultured cells contained 5 pg of the 474 base species per 30 pg total RNA, and 6.8 pg (per 30 pg of total RNA) of the 446 base species. Similarly, the tumor tissue contained 3.4 pg of the 414 base species and 4.6 pg of the 446 base species, both per 30 p g of total RNA. Total RNA from a mesoblastic nephroma, which produces aFGF but not bFGF." and total RNA from an osteogenic sarcoma, which does not produce bFGF. gave no signal in these assays indicating less than 0.03 pg/30 pg total RNA based on the signal intensity of the control sense strand (Fig 6) . These data, coupled with the biologic activity demonstrated in appeared to be a secondary S phase (S,) containing 1.8% of the cells, which likely corresponds to the 2% binucleated cells observed morphologically. After 4 days of PMA treatment. the 2N peak decreased by 40%. whereas the S, phase and 4N cells increased to 13.7% and 21%. respectively (Fig 7F) . This occurred even though the cellular proliferation rate decreased by 60% (data not shown). In addition, 8.1% of the treated cells contained an 8N or greater DNA content (8N + S,) .
I SC U SS IO N
A human megakaryocytic leukemia cell line, designated CHRF-288-11. has been successfully established in tissue culture starting with cells in a solid tumor. Establishment of the cell line required the presence of adherent bone marrow stromal cells. which are composed of macrophages. adipocytes, fibroblasts and endothelial cell~.'~.""' Such cells have been shown to produce hematopoietic growth factors,'639 as well as producing a microenvironment sufficient for supporting hematopoiesis. Such an adaptation scheme may be beneficial for other cell types that are normally found in the marrow. This is a novel procedure. and may prove to be widely applicable to a variety of cell types. The fact that the CHRF-288-1 I cells could be weaned from the stromal layer suggests that the importance of stromal cell derived growth factors in the proliferation of CHRF-288 cells has diminished with continuous culturing, and that the cells themselves are producing an autocrine growth factor.
The cloned cells appear to be of the megakaryocytic lineage as determined by a wide variety of criteria (Figs 3 through 7 and Table I ). The only markers expressed by the line that one might not expect to find on megakaryocytes are the HLA-DR antigen and the MY7 (CD13) and MY9 (CD38) markers. HLA-DR antigens are found on a variety of cell types. including R cdls, but they have also been identified on early stage megakaryoblasts as well.'.21 The MY7 marker (CD-13) is primarily expressed on peripheral blood monocytes and granulocytes. 5% to 40% of normal bone mononuclear cells. and 80% of all acute myeloid leukemia cases. It is not usually found on erythrocytes. Table 2 . Growth Factor A c t M y in CHRF-288-11 c.lh G " Factor Activity size and 29% to 30% appeared to contain two nuclei (Fig 7B) . After 4 days of PMA treatment, the percentage of binucleated cells remained approximately the same; however. 6% of the cells had four to eight nuclear lobes (Fig 7C) . After 6 days of PMA treatment. the percentage of responding cells was the same as day 4; however. occasional cells with up to 16 nuclear lobes were evident (Fig 7D) . Flow cytometric analysis using propidium iodide labeling confirmed that these morphologic changes represented increases in the ploidy values of the treated cells. Untreated CHRF-288-11 cells demonstrated a fairly normal DNA cell cycle pattern ( Fig  7E) , with 84.6% of the cells in the 2N (G,/G,) 2N. 4N and 8N peaks are 48.3.96.6. and 190.0. respectively. For each analysis, M) .OW cells were counted.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From 1260 FUGMAN ET AL platelets, or lympho~ytes.~~,~' The presence of CD-13 on the CHRF-288-11 cells is not necessarily surprising, since a recent report4' has indicated that 5% to 10% of megakaryoblastic leukemia cases shown to be positive for GPIIb-IIIa were also positive for CD-13, indicating that cells of megakaryocytic origin often express both markers. In addition, two other recently described megakaryocytic cell lines, the DAMI line'' and T-33' are positive for CD-13 as well. The presence of this antigen may indicate the immature aspect of the and it is possible that if the cells are induced to differentiate to a more mature form, the expression of this marker would decrease. The MY9 (CD-38) marker is similar in cell expression to MY7,44 but it too has been detected on other cells derived from megakaryoblastic leukemias,4' and the T-33 cell line,* and may also be represented on immature forms of this cell type as well.
Unlike the K56246 and DAMI" cell lines, the CHRF-288-1 1 cell line does not express erythroid characteristics, indicating that the cells are not biphenotypic. The cells are remarkably homogenous, in both karyotype and marker expression. Greater than 95% of the cells express GPIIb-IIIa and PF4. This is in contrast to the MEG-01s cell line," in which only 40% of the cells are positive for GPIIb-IIIa, and the DAMI cell line," which does not exhibit a constant karyotype. CHRF-288-11 cells also demonstrated a potential for hyperploidy in response to phorbol esters (Fig 7) , similar to results reported for the EST-IU cell line,13 the MEG-01s cell line," the DAMI cell line," and the T-33 cell line.8 In a normal cell cycle pattern, the S phase and 4N cells would be expected to decrease if the rate of proliferation also decreased. However, under conditions of PMA treatment of CHRF-288-11 cells, in which the proliferation rate decreased by 60%, the number of cells in the S and 4N phases actually increased, and many cells exhibited ploidy values of greater than 4N as well. These data indicate that there has been a transgression from the classical cell cycle pattern, and that many of the cells fall into a pattern of nuclear replication without cytoplasmic division, which is consistent with megakaryocytic development. Thus, while further studies are required, the CHRF-288-11 cell line may prove to be a valuable model for the study of megakaryocytes and megakaryocyte-associated functions.
